We only take on 4 clients per month. Join our October cohort. 1 spot left.
Welcome to another episode of Category Visionaries, the show that explores the future of tech with innovative B2B founders. In today’s episode, we’re speaking with Dr. Thomas Oakley, CEO of Feedback plc, a medical imaging technology company that has raised £20 million in funding.
As a medical device company, Feedback must balance the desire to move quickly and iterate based on customer feedback with the need to prioritize patient safety and risk management. Dr. Oakley highlights the importance of developing a unique skill set that allows for agile development within a regulated environment.
While being a public company brings added scrutiny and pressure from shareholders, Dr. Oakley emphasizes the importance of staying focused on delivering value to customers and sitting close to their needs. By prioritizing product quality and user experience, the team can drive long-term growth and trust that the share price will follow.
The rigorous certification process for medical devices can be a barrier to entry, but it also creates opportunities to differentiate from both larger competitors and smaller startups. By leveraging its status as a certified platform for image display and collaboration, Feedback can tackle challenges and integrate systems in ways that others cannot.
Selling technology into healthcare, particularly in the NHS, requires a high degree of persistence and discipline. With decision-making often involving multiple stakeholders and lengthy procurement processes, founders must be prepared to engage repeatedly and chase opportunities relentlessly to close deals.
The COVID-19 pandemic accelerated the adoption of remote collaboration tools in healthcare, and Feedback seized this opportunity to enable clinicians to treat patients across vast distances. As the company expands internationally, it envisions a future where its platform can serve as a "digital glue" connecting care settings and deploying innovative technologies on a global scale.